Key Takeaways
- If you experience 15 or more headache days per month, you may have chronic migraine, a neurological disorder that often requires preventive therapy.
- Vyepti® (eptinezumab-jjmr) is an FDA-approved monoclonal antibody infusion used for the preventive treatment of migraine in adults.
- Vyepti works by blocking CGRP (calcitonin gene-related peptide), a key protein involved in migraine activation.
- Treatment is administered once every 12 weeks for consistent prevention without daily medication.
- Smart Infusion Therapy Services provides Vyepti infusion treatment through its neurology infusion programs in Eau Claire, Wausau, Madison, and Onalaska, WI, offering comfortable, patient-centered care. Schedule an appointment today to explore migraine infusion therapy options.
When Migraines Keep Coming Back
If you experience recurring migraines, symptoms may include:
- Throbbing or pulsing head pain
- Sensitivity to light, sound, or odors
- Nausea or vomiting
- Visual disturbances (aura)
- Neck stiffness or facial pressure
- Fatigue or difficulty concentrating
Chronic migraine is clinically defined as 15 or more headache days per month, with at least 8 days meeting criteria for migraine.
Migraines are not simply stress-related headaches. They are a neurologic condition involving abnormal sensory processing, neurovascular inflammation, and dysregulated pain signaling pathways. For many patients, over-the-counter medications or acute “rescue” prescriptions are not sufficient.
When attacks are frequent or disabling, preventive therapy may be appropriate.
Why Preventive Migraine Treatment Matters
Acute medications treat migraine attacks after they begin. Preventive therapies aim to:
- Reduce the number of monthly migraine days
- Shorten attack duration
- Decrease symptom severity
- Reduce reliance on rescue medications
- Improve functional stability
If migraines are interfering with work, family responsibilities, or daily routines, a preventive infusion therapy such as Vyepti may help reduce overall disease burden.
How Vyepti Works: Targeting the CGRP Pathway
Vyepti is a CGRP monoclonal antibody that binds to calcitonin gene-related peptide and prevents it from activating migraine-related inflammatory and pain pathways.
What Is CGRP?
CGRP (calcitonin gene-related peptide) is a neuropeptide strongly associated with migraine attacks.
During a migraine episode, CGRP levels increase. This contributes to:
- Dilation of blood vessels
- Neurogenic inflammation
- Amplification of pain signaling in the trigeminal system
CGRP plays a central role in initiating and sustaining migraine activity.
What Vyepti Does
By binding directly to CGRP, Vyepti prevents it from attaching to its receptor. This mechanism helps:
- Reduce monthly migraine days
- Decrease migraine intensity
- Limit escalation of symptoms
- Support long-term preventive control
Rather than stopping pain after it begins, Vyepti works upstream in the migraine cascade.
What Clinical Studies Show
Vyepti has demonstrated meaningful reductions in monthly migraine days in patients with both episodic and chronic migraine.
Once-Quarterly Dosing
Vyepti is administered as an IV infusion once every 12 weeks, allowing sustained therapeutic levels without daily or monthly injections.
Early Onset of Effect
Many patients experience reductions in migraine frequency soon after their first infusion, with continued improvement over subsequent treatment cycles.
Sustained Benefit
With consistent dosing, patients often see continued decreases in migraine frequency and severity.
For individuals seeking a structured, long-term preventive strategy, this schedule can offer predictability and convenience.
How Vyepti Compares to Other Migraine Treatments
| Treatment Type | What It Does | Limitations |
|---|---|---|
| Oral preventive medications | Reduce migraine frequency | Daily dosing, possible side effects |
| Rescue medications | Stop migraines in progress | Does not prevent future attacks |
| Lifestyle changes | Reduce triggers | Often not enough for chronic migraine |
| Vyepti infusion | Prevents migraine activity by blocking CGRP | Requires scheduled infusion appointments |
Vyepti is distinguished by its targeted biologic mechanism and infrequent dosing schedule.
What to Expect at Smart Infusion Therapy Services
Starting infusion therapy may feel unfamiliar. Our goal is to provide safe administration in a calm, structured setting.
Smart Infusion Therapy Services is an outpatient infusion center in Wisconsin specializing in administering neurologist- or physician-ordered biologic and specialty infusion therapies.
Referral and Coordination
An order from your neurologist or prescribing provider is required before starting Vyepti. Our team assists with insurance verification and the coordination of required documentation.
During Your Infusion
Your appointment includes:
- Care from experienced infusion nurses
- Monitoring throughout your treatment
- Comfortable seating
- WiFi, snacks, and beverages
- Support if you experience treatment-related anxiety
After your visit, we share detailed documentation with your referring provider to ensure continuity of care.
Locations in Wisconsin
Vyepti infusion therapy is available at Smart Infusion Therapy Services in:
Find your nearest location on the Smart Infusion Therapy Services locations page.
Discover a Preventive Approach Designed for Chronic Migraine Stability
Chronic migraine can significantly disrupt daily life. Preventive infusion therapy such as Vyepti offers a mechanism-based approach designed to reduce attack frequency and improve functional stability.
Smart Infusion Therapy Services is an outpatient infusion center in Wisconsin providing Vyepti infusion therapy through its neurology infusion programs in Eau Claire, Wausau, Madison, and Onalaska. To learn more about migraine infusion therapy or request an appointment, contact our team today.
Frequently Asked Questions
How does Vyepti help prevent migraine headaches?
Vyepti blocks specific migraine-triggering proteins involved in the CGRP signaling pathway, helping reduce both the frequency and severity of migraine attacks over time.
How often do I receive Vyepti infusions?
Vyepti is typically administered once every 12 weeks. Your referring provider will recommend the best schedule for your treatment plan.
Is Vyepti used to treat active migraine attacks?
No. Vyepti is a preventive treatment designed to reduce how often migraines occur rather than stop a migraine that has already started.
Do I need a referral to receive Vyepti infusion therapy?
Yes. A healthcare provider must order Vyepti infusion therapy. Smart Infusion Therapy Services can help coordinate this referral if needed.
What is the infusion experience like?
Vyepti infusions are provided in a patient-focused environment with comfortable seating, WiFi, snacks, and beverages, along with attentive nursing care.
